Cancer Cells Prevent Immune Cells from Producing Cancer Killing Chemicals
Denis Guttridge, PhD. Credit: Ohio State University
A new study by researchers at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James) identifies a substance released by pancreatic cancer cells that protects them from attack by immune cells called macrophages.
The study found that the substance, called Gdf-15, might be required for the development of early pancreatic tumors. The research also revealed that a molecule pronounced N-F-kappa-B (NF-kB) helps tumor cells produce Gdf-15.
When macrophages take up the Gdf-15, it prevents them making nitric oxide and tumor necrosis factor, two chemicals they release to kill cancer cells. Ironically, the researchers found that NF-kB in macrophages plays an important role in the production of nitric oxide and tumor necrosis factor.
The findings are reported in the Journal of Clinical Investigation.
“This study shows that GDF-15 plays an important role in the development of pancreatic cancer and might be required for the development of early pancreatic tumors,” says principal investigator Denis Guttridge, PhD, professor of Cancer Biology and Genetics at Ohio State and associate director for basic research.
“We believe that this mechanism for disarming macrophages develops early in cancer cells, enabling small tumors to survive and grow,” adds Guttridge, who also is in the OSUCCC – James Molecular Carcinogenesis and Chemoprevention Program. “These findings support the need for preclinical studies to determine the role of GDF-15 in the development of pancreatic cancer.”
Guttridge and his colleagues conducted the study using pancreatic-cancer cell lines, cells from patient tumors and an animal model. Key findings include:
• NF-κB is a direct regulator of Gdf-15;
• GDF-15 suppresses macrophage cell-killing activity by inhibiting the production of nitric oxide and tumor necrosis factor;
• Both GDF-15 and NF-kB are overexpressed in patients with pancreatic cancer.
“Overall,” Guttridge says, “our results reveal that NF-κB is responsible for the synthesis and secretion of GDF-15 from pancreatic tumor cells, and that GDF-15 then inhibits NF-κB activity in macrophages and blocks them from killing tumor cells.”
Funding from Pelotonia, an annual bicycling event that raises funds for research at the OSUCCC – James, helped support this research.
This article has been republished from materials provided by Ohio State University. Note: material may have been edited for length and content. For further information, please contact the cited source.
Ratnam, N. M., Peterson, J. M., Talbert, E. E., Ladner, K. J., Rajasekera, P. V., Schmidt, C. R., ... & Williams, T. M. (2017). NF-κB regulates GDF-15 to suppress macrophage surveillance during early tumor development. The Journal of Clinical Investigation, 127(10), 3796-3809.
British Pharmacological Society’s Drug Discovery of the Year 2018 AnnouncedNews
A new medicine used to treat an ultra-rare inherited disorder which leaves babies without a fully functioning immune system has been named the British Pharmacological Society’s Drug Discovery of the Year 2018.READ MORE
What Does the Future of Vaccines and Immunotherapy Look Like?News
Innovative biomaterials could enhance vaccines against HIV and other infectious diseases and immunotherapies for patients with cancer or dampen responses in autoimmune disorders, allergies and transplanted organ recipients. A review of these efforts was recently released.READ MORE